494 related articles for article (PubMed ID: 30200265)
1. Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled.
Klymenko Y; Nephew KP
Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30200265
[TBL] [Abstract][Full Text] [Related]
2. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.
Ritch SJ; Telleria CM
Front Endocrinol (Lausanne); 2022; 13():886533. PubMed ID: 35574025
[TBL] [Abstract][Full Text] [Related]
3. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
[TBL] [Abstract][Full Text] [Related]
4. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer.
Li Y; Wang W; Wang D; Zhang L; Wang X; He J; Cao L; Li K; Xie H
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553542
[TBL] [Abstract][Full Text] [Related]
6. Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.
Klymenko Y; Kim O; Stack MS
Cancers (Basel); 2017 Aug; 9(8):. PubMed ID: 28792442
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.
Uno K; Iyoshi S; Yoshihara M; Kitami K; Mogi K; Fujimoto H; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Kanayama T; Tomita H; Enomoto A; Kajiyama H
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457198
[TBL] [Abstract][Full Text] [Related]
8. Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment.
Jazwinska DE; Kulawiec DG; Zervantonakis IK
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C721-C730. PubMed ID: 37545408
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis.
Chen LY; Huang RL; Su PH; Chu LH; Weng YC; Wang HC; Lai HC; Wen KC
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563509
[TBL] [Abstract][Full Text] [Related]
10. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
11. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.
Nguyen VHL; Yue C; Du KY; Salem M; O'Brien J; Peng C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993038
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review.
Dhaliwal D; Shepherd TG
Clin Exp Metastasis; 2022 Apr; 39(2):291-301. PubMed ID: 34822024
[TBL] [Abstract][Full Text] [Related]
13. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.
Weidle UH; Birzele F; Kollmorgen G; Rueger R
Cancer Genomics Proteomics; 2016 11-12; 13(6):407-423. PubMed ID: 27807064
[TBL] [Abstract][Full Text] [Related]
15. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.
Usui A; Ko SY; Barengo N; Naora H
Mol Cancer Res; 2014 Apr; 12(4):504-13. PubMed ID: 24448686
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
[TBL] [Abstract][Full Text] [Related]
17. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.
Yousefi M; Dehghani S; Nosrati R; Ghanei M; Salmaninejad A; Rajaie S; Hasanzadeh M; Pasdar A
Cell Oncol (Dordr); 2020 Aug; 43(4):515-538. PubMed ID: 32418122
[TBL] [Abstract][Full Text] [Related]
18. Complex cross-talk between EZH2 and miRNAs confers hallmark characteristics and shapes the tumor microenvironment.
Hillyar CR; Kanabar SS; Rallis KS; Varghese JS
Epigenomics; 2022 Jun; 14(11):699-709. PubMed ID: 35574589
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk Between Inflammatory Signaling and Methylation in Cancer.
Das D; Karthik N; Taneja R
Front Cell Dev Biol; 2021; 9():756458. PubMed ID: 34901003
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites-Correlation of tissue microarray and cytology microarray.
Toth L; Nagy B; Mehes G; Laszlo E; Molnar PP; Poka R; Hernadi Z
Pathol Res Pract; 2018 Jul; 214(7):978-985. PubMed ID: 29801775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
